The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen-receptor gene sequences

Leukemia and Lymphoma

Volumn 20, Issue 3-4, 1996, Pages 181-197

  Roberts, W Mark ^a   Estrov, Zeev ^b   Kitchingman, Geoffrey R ^c   Zipf, Theodore F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Acute lymphoblastic leukemia (ALL); Antigen receptor genes; Minimal residual disease (MRD); Polymerase chain reaction (PCR)

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW; CHILDHOOD LEUKEMIA; HUMAN; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; RELAPSE; REVIEW;

BONE MARROW; CHILD; DNA, NEOPLASM; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0029560597     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051607     Document Type: Article

References (12)

1. Ryan, D. H. and Van Dongen, J. J. M. (1988) Detection of residual disease in acute leukemic using immunological markers, Bennett, J. M. and Foon, K. A. (eds.). Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias. Norwell, MA, Kluwer Academic Publishers, pp. 173-207.
2. Pratt, W. B., Ruddon, R. W., Ensminger, W. D. and Maybaum, J. (1994) Determinants of drug responsiveness, The Anticancer Drugs. New York, Oxford University Press, pp. 26-49.
3. Pui, C. H., Crist, W. M. and Look, A. T. (1990) Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood, 76, 1449-1463.
4. VanDongen, J. J. M. and Wolvers-Tettero, I. L. M. (1991) Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin. Chim. Acta, 198, 93-174.
5. Steward, C. G., Goulden, N. J., Katz, F., Baines, D., Martin, P. G., Langlards, K., Potter, M. N., Chessells, J. M. and Oakhill, A. (1994) A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor δ gene rearrangement between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood, 83, 1355-1362.
6. D'Auriol, L., Macintyre, E., Galibert, F. and Sigaux, F. (1989) In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. Leukemia, 3, 155-158.
7. Brisco, M.J., Tan, L. W., Orsborn, A. M. and Morley, A. A. (1990) Development of a highly sensitive assay based on the polymerase chain reaction for rare B-lymphocyte clones in a polyclonal population. Br. J. Haematol., 75, 163-167.
8. Jonsson, O. G., Kitchens, R. L., Scott, F. C. and Smith, R. G. (1990) Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood, 76, 2072-2079.
9. Nizet, Y., Martial, P., Vaerman, J. L., Philippe, M., Wildmann, C., Staelens, J. P., Cornu, G., Ferrant, A., Michaux, J. L. and Sokal, G. (1991) Follow-up of residual disease (MRD) in B lineage acute leukemias using a simplified PCR strategy; evolution of MRD rather than its detection is correlated with clinical outcome. Br. J. Haematol., 79, 205-210.
10. Yamada, M., Wasserman, R., Lange, B., Reichard, B. A., Womer, R. B. and Rovera, G. (1990) Minimal residual disease in childhood B-Iineage lymphoblastic leukemia. N. Engl. J. Med., 323, 448-455.
11. Macintyre, E., D'Auriol, L., Amesland, F., Loiseau, P., Chen, Z., Boumsell, L., Galibert, F. and Sigaux, F. (1989) Analysis of junctional diversity in the preferential VS-J81 rearrangement of fresh T-acute lymphoblastic leukemia cells by in vitro gene amplification and direct sequencing. Blood, 74, 2053-2061.
12. Beishuizen, A., Hahlen, K., Van Wering, E. R. and Van Dongen, J. J. M. (1991) Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction. N. Engl. J. Med., 324, 772-773.